TGR-1202 Alone and in Combination With Either Nab-paclitaxel + Gemcitabine or With FOLFOX in Patients With Select Relapsed or Refractory Solid Tumors
TG Therapeutics, Inc.
TG Therapeutics, Inc.
Eli Lilly and Company
Eli Lilly and Company
Mayo Clinic
Valerio Therapeutics